ES8404693A1 - Procedimiento de preparacion de nuevos amino-14 esteroides. - Google Patents

Procedimiento de preparacion de nuevos amino-14 esteroides.

Info

Publication number
ES8404693A1
ES8404693A1 ES524614A ES524614A ES8404693A1 ES 8404693 A1 ES8404693 A1 ES 8404693A1 ES 524614 A ES524614 A ES 524614A ES 524614 A ES524614 A ES 524614A ES 8404693 A1 ES8404693 A1 ES 8404693A1
Authority
ES
Spain
Prior art keywords
preparation
amino
steroid derivatives
therapeutical use
therapeutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES524614A
Other languages
English (en)
Spanish (es)
Other versions
ES524614A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nativelle SA Ets
Original Assignee
Nativelle SA Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8214038A external-priority patent/FR2531715B1/fr
Priority claimed from FR8310031A external-priority patent/FR2548191B1/fr
Application filed by Nativelle SA Ets filed Critical Nativelle SA Ets
Publication of ES524614A0 publication Critical patent/ES524614A0/es
Publication of ES8404693A1 publication Critical patent/ES8404693A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011Unsubstituted amino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/0075Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified substituted in position 17 alfa

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
ES524614A 1982-08-12 1983-07-30 Procedimiento de preparacion de nuevos amino-14 esteroides. Expired ES8404693A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8214038A FR2531715B1 (fr) 1982-08-12 1982-08-12 Amino-14 steroides, application en therapeutique, et procede de preparation
FR8310031A FR2548191B1 (fr) 1983-06-17 1983-06-17 Amino-14 steroides, application en therapeutique et procede de preparation

Publications (2)

Publication Number Publication Date
ES524614A0 ES524614A0 (es) 1984-05-01
ES8404693A1 true ES8404693A1 (es) 1984-05-01

Family

ID=26223042

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524614A Expired ES8404693A1 (es) 1982-08-12 1983-07-30 Procedimiento de preparacion de nuevos amino-14 esteroides.

Country Status (8)

Country Link
US (1) US4584289A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0101383B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1216283A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3367598D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK167442B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8404693A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR78920B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE55630B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4226593A (en) * 1992-06-26 1994-01-24 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
CZ86796A3 (en) * 1993-09-24 1996-10-16 Procter & Gamble Novel deoxy and on oxygen substituted sugar derivatives of aminosteroidal compounds
CA2182530A1 (en) * 1993-09-24 1995-03-30 Paul Michael Dybas Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry
US5922703A (en) * 1993-09-24 1999-07-13 The Procter & Gamble Company Urethane-containing aminosteroid compounds
ATE502041T1 (de) * 1997-04-15 2011-04-15 Csir Nicht-therapeutische methode zur appetitunterdrückung
GB2355657B (en) 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD138983A1 (de) * 1978-09-26 1979-12-05 Schmidt Hans Joerg Verfahren zur herstellung von neuen n-funktionellen cardenolidderivaten
FR2464270A1 (fr) * 1979-08-31 1981-03-06 Nativelle Sa Ets Nouveaux derives d'amino-14 steroides, et procede pour leur preparation

Also Published As

Publication number Publication date
ES524614A0 (es) 1984-05-01
DE3367598D1 (en) 1987-01-02
DK167442B1 (da) 1993-11-01
DK364483D0 (da) 1983-08-10
IE831887L (en) 1984-02-12
GR78920B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-10-02
EP0101383B1 (fr) 1986-11-12
US4584289A (en) 1986-04-22
CA1216283A (fr) 1987-01-06
IE55630B1 (en) 1990-12-05
EP0101383A1 (fr) 1984-02-22
DK364483A (da) 1984-02-13

Similar Documents

Publication Publication Date Title
DE3372769D1 (en) 3-aminoquinuclidin derivatives, process for their preparation and their use as therapeutical agents
ZA83743B (en) Pyrazolooxazines,pyrazolothiazines,and pyrazoloquinolines,process for their preparation and their use as medicaments
DE3461466D1 (en) 3',4',5,7-tetrahydroxyflavone derivatives, process for their preparation and their therapeutical use
EP0119954A3 (en) 3-amino-1-benzazepin-2-one-1-alcanoic acids, process for their preparation, their pharmaceutical preparation as well as their therapeutic use
DE3160480D1 (en) Pyridoxine derivatives, process for their preparation and their therapeutical use
EP0152402A4 (en) TABLE FOR THERAPY.
DE3163162D1 (en) Platinum-isocitrate complex, process for its preparation and its therapeutical application
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
DE3165788D1 (en) Thienopyridinone derivatives, process for their preparation and their therapeutical use
EP0186628A3 (en) Pentaerythritdiphosphites, process for their preparation and their use as stabilizers
IL67808A (en) Plant-promoting preparations,process for manufacture thereof and methods for the use thereof
DE3371199D1 (en) Novel 6-nitroprostaglandin derivatives, process for production thereof, and use thereof
DE3362327D1 (en) (1-arylcyclobutyl) alkylamine derivatives, their preparation and their use as therapeutic agents
DE3463041D1 (en) Tributylphenolether-glycidyl-sulphonates, process for their preparation and their use
DE3162203D1 (en) Isoindoline derivatives, process for their preparation and their use
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
DE3362189D1 (en) 14-amino-steroid derivatives, process for their preparation and their use in therapy
EP0121081A3 (en) Azolylmethylcycloalkanes, process for their preparation and their therapeutical use
ZA842223B (en) Method for the preparation of 1,8-dihydroxy-10-acyl-9-anthrones,especially for use in the treatment of psoriasis
DE3377646D1 (en) Tetrahydrophthalimides, and their production and use
AU2192783A (en) 3:,5:-diarabinosides preparation and application in therapy
DE3378823D1 (en) Process for the preparation of 2,4,5,6-tetrachloropyrimidine
ZA832742B (en) 1-sulfo-2-azetidinone derivatives,their production and use
DE3369132D1 (en) Process for the preparation of isomelamines, and their use
ZA832093B (en) N-substituted- tetrahydrothiazines,process for their preparation,and their use as pesticides

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041004